If penicillin was discovered on moldy bread, who's to say the next miracle drug won't be born from AI hallucinations ...

Lilly and NVIDIA launch AI co-innovation lab to tackle drug discovery challenges.NVIDIA collaborates with Thermo Fisher to ...

"The UN estimates that by 2050, common bacterial infections could kill more people than cancer," says Arnold Mathijssen, a ...

AI therapeutics company built on causal biology, today announced the acquisition of CombinAbleAI and the launch of insitro's TherML™ (Therapeutic Machine Learning) platform. The acquisition, which is ...

A simulation of an individual patient's brain tumors, kept up to date with readily available data, can identify whether dietary treatments and drugs ...

Nvidia (NASDAQ:NVDA) expanded its BioNeMo platform with new models, tools and data-processing libraries aimed at connecting ...

Ignite Next, the independent scale-up program for deep tech innovation, today announced that Synopsys, the leader in engineering solutions from silicon to systems, has joined the program as a focus ...

New scientific methods could one day render animal studies—the standard in research laboratories for more than 100 ...

Multiply Labs, a leader in robotic biomanufacturing, today announced a landmark milestone in its mission to scale production of cell and gene therapies; The company is now leveraging NVIDIA's open ...

We know the genes, but not their functions—to resolve this long-standing bottleneck in microbial research, a joint research ...

Molecular mechanism uncovered in mice by UC Santa Cruz researchers reveals how a father’s diet, stress, and other ...